Fulcrum Capital LLC Increases Stock Holdings in CME Group Inc. (NASDAQ:CME)

Fulcrum Capital LLC lifted its position in CME Group Inc. (NASDAQ:CME) by 1.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,331 shares of the financial services provider’s stock after buying an additional 678 shares during the quarter. CME Group makes up approximately 2.1% of Fulcrum Capital LLC’s portfolio, making the stock its 14th biggest holding. Fulcrum Capital LLC’s holdings in CME Group were worth $9,782,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. CVA Family Office LLC lifted its holdings in shares of CME Group by 11.8% in the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after buying an additional 46 shares in the last quarter. Capital Advisors Ltd. LLC lifted its holdings in shares of CME Group by 4.3% in the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after buying an additional 48 shares in the last quarter. Lester Murray Antman dba SimplyRich lifted its holdings in shares of CME Group by 0.7% in the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after buying an additional 50 shares in the last quarter. Essex LLC lifted its holdings in shares of CME Group by 3.3% in the first quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock worth $355,000 after buying an additional 52 shares in the last quarter. Finally, Quent Capital LLC lifted its holdings in shares of CME Group by 10.2% in the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after buying an additional 55 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on CME. Barclays upped their price objective on shares of CME Group from $209.00 to $219.00 and gave the stock an “equal weight” rating in a research report on Monday, October 7th. Bank of America upped their price objective on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Deutsche Bank Aktiengesellschaft upped their price objective on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Oppenheimer upped their price objective on shares of CME Group from $228.00 to $245.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Finally, The Goldman Sachs Group upped their price objective on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, CME Group presently has a consensus rating of “Hold” and an average target price of $220.07.

CME Group Stock Up 0.4 %

Shares of NASDAQ CME opened at $227.14 on Thursday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a one year low of $190.70 and a one year high of $230.12. The stock has a market capitalization of $81.79 billion, a P/E ratio of 25.84, a PEG ratio of 7.76 and a beta of 0.55. The firm’s 50 day simple moving average is $218.08 and its two-hundred day simple moving average is $208.66.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same quarter last year, the business earned $2.30 earnings per share. The business’s revenue was up 12.7% on a year-over-year basis. As a group, analysts expect that CME Group Inc. will post 10.04 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.03%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio is 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.